Newswire (Published: Wednesday, June 5, 2019, Received: Wednesday, June 5, 2019, 6:04:53 PM CDT)

Word Count: 429

2019 JUN 05 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Daily -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting originating from Durham, United States, by NewsRx correspondents, research stated, “Prostate cancer (PCa) remains a leading cause of mortality in US and other countries. Preclinical and clinical studies have examined the role of nutrition and dietary intake on the incidence and progression of PCa with mixed results.”

Financial support for this research came from NIH.

Our news editors obtained a quote from the research from Duke University, “The objective of this chapter is to provide an update of recent published literature and highlight progress in the field. Low carbohydrate intake, soy protein, omega 3 fat, green teas, tomatoes and tomato products and the herbal mixture-zyflamend showed promise in reducing PCa risk or progression. On the contrary, a higher animal fat intake and a higher beta-carotene status may increase risk. A ‘U’ shape relationship may exist between folate, vitamin C, vitamin D and calcium with PCa risk. Despite the inconclusive findings, the potential for a role of dietary intake for the prevention and treatment of PCa remains promising. Maintaining a healthy body weight and following a healthy dietary pattern including antioxidant rich fruits and vegetables, reduced animal fat and refined carbohydrates, should be encouraged. Despite the inconclusive findings, the potential for a role of dietary intake for the prevention and treatment of PCa remains promising.”

According to the news editors, the research concluded: “Maintaining a healthy body weight and following a healthy dietary pattern including antioxidant rich fruits and vegetables, reduced animal fat and refined carbohydrates, should be encouraged.”

For more information on this research see: An Update of Research Evidence On Nutrition and Prostate Cancer. Urologic Oncology Seminars and Original Investigations, 2019;37(6):387-401. Urologic Oncology Seminars and Original Investigations can be contacted at: Elsevier Science Inc, Ste 800, 230 Park Ave, New York, NY 10169, USA.

The news editors report that additional information may be obtained by contacting P.H. Lin, Duke University, Medical Center, Dept. of Medicine, Durham, NC 27710, United States. Additional authors for this research include W. Aronson and S.J. Freedland.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.urolonc.2017.10.006. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)

Companies

Duke University

Places

North America
United States
Americas
North Carolina
New York
Durham
New York City

Subjects

Science and Technology
      Scientific Research
            Medical Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Health Sciences
            Medical Research
      Wellness
            Diet and Nutrition